← Back to Clinical Trials
Recruiting NCT07003672

NCT07003672 Role of Regional Lung Compliance and Dynamic Transpulmonary Driving Pressure in the Liberation Difficulty in Tracheostomized Patients Receiving Prolonged Mechanical Ventilation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07003672
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Weaning Failure
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2025-01-16
Primary Completion 2028-06-30

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2025-01-16 with a primary completion date of 2028-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project focuses on the analysis of the correlation between transpulmonary driving pressure and uneven lung ventilation and regional lung compliance in patients using prolonged mechanical ventilation (PMV), in order to understand the clinical occurrence of failure of the final spontaneous breathing test and inability to breathe. Respiratory physiology impairments in patients successfully discharged from respirators.

Eligibility Criteria

Inclusion Criteria: * Post-tracheostomy patients who are transferred to the subacute respiratory care ward of National Taiwan University Hospital must use respirators for at least 14 days; * Be at least 20 years old; * The oxygen concentration required when using the respirator does not exceed 50% Exclusion Criteria: * The vital signs are unstable or require continuous use of vasopressors; * Pregnancy; * Chronic obstructive pulmonary disease or asthma; * Those who have contraindications to the placement of esophageal pressure balloons, such as abnormal blood coagulation, esophageal varices, and those who have undergone esophageal or gastric surgery in the past six months; * Those who have contraindications to the use of electrical impedance tomography, such as heart rhythm regulators.

Contact & Investigator

Central Contact

Jih-Shuin Jerng, MD, PhD, Principal Investigator

✉ jsjerng@ntu.edu.tw

📞 +886-2-23123456

Frequently Asked Questions

Who can join the NCT07003672 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Weaning Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07003672 currently recruiting?

Yes, NCT07003672 is actively recruiting participants. Contact the research team at jsjerng@ntu.edu.tw for enrollment information.

Where is the NCT07003672 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT07003672 clinical trial?

NCT07003672 is sponsored by National Taiwan University Hospital. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology